A confirmatory trial of hysterectomy with minimal parametrectomy for stage IB1 cervical cancer involving a tumor diameter of 2 cm or less: a Japan Clinical Oncology Group study (JCOG1101)
Authors:
- Takahide ArimotoTATakahide Arimoto
- Takahiro KasamatsuTKTakahiro Kasamatsu
- Ryunosuke MachidaRMRyunosuke Machida
- Takafumi ToitaTTTakafumi Toita
- Hiroaki KobayashiHKHiroaki Kobayashi
- Haruhiko FukudaHFHaruhiko Fukuda
- Takashi OndaTOTakashi Onda
- Toru NakanishiTNToru Nakanishi
- Harushige YokotaHYHarushige Yokota
- Shoji KamiuraSKShoji Kamiura
- Kazuhiro TakeharaKTKazuhiro Takehara
- Hirokuni TakanoHTHirokuni Takano
Open Access
- 1 January 2027
- journal article
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 38
Abstract
Arimoto T, et al. J Gynecol Oncol. 2027 ;38:e8. https://doi.org/10.3802/jgo.2027.38.e8Keywords
Funding Information
- Labor and Welfare of Japan
- Japan Agency for Medical Research and Development (JP22ck0106588)
- National Cancer Center Research and Development Fund (23-A-17)
- National Cancer Center Research and Development Fund (26-A-4)
- National Cancer Center Research and Development Fund (29-A-3)
- National Cancer Center Research and Development Fund (2020-J-3)
- National Cancer Center Research and Development Fund (2023-J-03)
This publication has 19 references indexed in Scilit:
- ROCC/GOG-3043: a randomized controlled trial of robotic versus open surgery for early-stage cervical cancerInternational Journal of Gynecological Cancer, 2025
- Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trialThe Lancet, 2024
- Commentary on “Simple versus radical hysterectomy in women with low-risk cervical cancer” by Plante M. et al. published in The New England Journal of MedicineGynecologic Oncology, 2024
- Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A)Gynecologic Oncology, 2015
- Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)British Journal of Cancer, 2013
- Precise anatomy of the vesico-uterine ligament for radical hysterectomyGynecologic Oncology, 2007
- Class II versus Class III Radical Hysterectomy in Stage IB–IIA Cervical Cancer: A Prospective Randomized StudyGynecologic Oncology, 2001
- Tumor Size, Depth of Invasion, and Grading of the Invasive Tumor Front Are the Main Prognostic Factors in Early Squamous Cell Cervical CarcinomaGynecologic Oncology, 1999
- Modified Radical Hysterectomy for Early Ib Cervical CancerGynecologic Oncology, 1999
- Identification of a Low-Risk Subset of Patients with Stage IB Invasive Squamous Cancer of the Cervix Possibly Suited to Less Radical Surgical TreatmentGynecologic Oncology, 1995